Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.What you'll get out of this episode:Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.The need for diverse site participation and data inputs to improve trial accuracy and efficiency.The role of AI and technology in enhancing clinical trial processes.To learn more about our guests and their companies:Christine's LinkedIn https://www.linkedin.com/in/christinesenn/ Rohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/ Advarra LinkedIn https://www.linkedin.com/company/advarra/ Lokavant LinkedIn https://www.linkedin.com/company/lokavant/Advarra Website https://www.advarra.com/ Lokavant Website https://www.lokavant.com/en-us/Our sponsor for this episode is:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Ver todos los episodios